The UltraMind Solution (140 page)

6
. Bushara, K. O. 2005. Neurologic presentation of celiac disease.
Gastroenterology
128 (4 Suppl 1):S92–97. Review.

7
. Millward, C., et al. 2004. Gluten-and casein-free diets for autistic spectrum disorder.
Cochrane Database Syst Rev
2:CD003498. Review.

8
. Grosjean, B., and G. E. Tsia. 2007. NMDA neurotransmission as a critical mediator of borderline personality disorder.
J Psychiatry Neurosci
32 (2):103–15. Review.

9
. Niederhofer, H., and K. Pittschieler. 2006. A preliminary investigation of ADHD symptoms in persons with celiac disease.
J Atten Disord
10 (2):200–4.

10
. Martin, A., and D. Leslie. 2003. Trends in Psychotropic Medication Costs for Children and Adolescents, 1997–2000.
Arch Pediatr Adolesc Med
157: 997–1004.

11
. Scheffler, R. M., et al. 2007. The global market for ADHD medications.
Health Aff
26 (2):450–57.

12
. Bhatara, V., et al. 2004. National trends in concomitant psychotropic medication with stimulants in pediatric visits: Practice versus knowledge.
Atten Disord
7 (4):217–26.

13
. Kaufman, D. W., et al. 2002. Recent patterns of medication use in the ambulatory adult population of the United States. The Slone Survey.
JAMA
287:337–44.

14
. Herbert, M. R. 2005. Autism, a brain disorder, or a disorder that affects the brain?
Clin Neuropsychiatry
2 (6):354–79.

15
. U.C. Davis work, MIND institute work, Pardo C., Johns Hopkins.

16
. Selkoe, D. J., American College of Physicians; American Physiological Society. 2004. Alzheimer’s disease: mechanistic understanding predicts novel therapies.
Ann Intern Med
140 (8):627–38. Review.

17
. Yaffe, K., et al. 2004. The metabolic syndrome, inflammation, and risk of cognitive decline.
JAMA
292 (18):2237–2242.

18
. Ehninger, D., and G. Kempermann. 2007. Neurogenesis in the adult hippocampus.
Cell Tissue Res
.

Chapter 4: Why You Are Suffering from Brain Damage

1
. Johnson, R. J., et al. 2007. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.
Am J Clin Nutr
86 (4):899–906.

2
. George A. Bray, S. J. Nielsen, and B. M. Popkin. 2004. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity.
Am. J. Clinical Nutrition
79:537–43.

3
. Lenoir, M., et al. 2007. Intense sweetness surpasses cocaine reward.
PLoS ONE
2 (1):e698.

4
. Holford, P.
Optimum Nutrition for the Mind
(Laguna Beach: Basic Health Publications, 2004).

5
. Morris, M. C., et al. 2003. Dietary fats and the risk of incident Alzheimer disease.
Arch Neurol
60 (2):194–202.

6
. Ibid., 194–200.

7
. Trejo, J. L., et al. 2002. Sedentary life impairs self-reparative processes in the brain: The role of serum insulinlike growth factorI.
Rev Neurosci
13 (4):365–74. Review.

8
. Vaynman, S., and F. Gomez-Pinilla. 2006. Revenge of the “sit”: How lifestyle impacts neuronal and cognitive health through molecular systems that interface energy metabolism with neuronal plasticity.
J Neurosci Res
84 (4):699–715. Review.

9
. Cotman, C. W., N. C. Berchtold, and L. A. Christie. 2007. Exercise builds brain health: Key roles of growth factor cascades and inflammation.
Trends Neurosci
30 (9):464–72. Epub August 31, 2007.

10
. Blumenthal, J. A., et al. 2007. Exercise and pharmacotherapy in the treatment of major depressive disorder.
Psychosom Med
69 (7):587–96.

11
. Swaab, D. F., A. M. Bao, and P. J. Lucassen. 2005. The stress system in the human brain in depression and neurodegeneration.
Ageing Res Rev
4(2):141–94. Review.

12
. Doraiswamy, P. M., and G. L. Xiong. 2007. Does meditation enhance cognition and brain longevity?
Ann NY Acad Sci
.

13
. Gilliland, K., and D. Andress. 1981. Ad lib caffeine consumption, symptoms of caffeinism, and academic performance.
Am J Psychiatry
138 (4):512–14.

14
. O’Keefe, J. H., K.A. Bybee, and C. J. Lavie. 2007. Alcohol and cardiovascular health: the razor-sharp double-edged sword.
J Am Coll Cardiol
50 (11):1009–1014. Review.

15
. Anttila, T., et al. 2004. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: A prospective population based study.
BMJ
329 (7465):539.

16
. Mukamal, K. J., et al. 2003. Prospective study of alcohol consumption and risk of dementia in older adults.
JAMA
289 (11):1405–1413.

17
. Volkow, N. D., et al. 1992. Decreased brain metabolism in neurologically intact healthy alcoholics.
Am J Psychiatry
149 (8):1016–1022.

18
. Brunnemann, K., and D. Hoffmann. 1991. Analytical studies on tobacco-specific N-nitrosamines in tobacco and tobacco smoke.
Crit Rev Toxicol
21:235–40.

19
. Pergadia, M., et al. 2004. Double-blind trial of the effects of tryptophan depletion on depression and cerebral blood flow in smokers.
Addict Behav
29 (4):665–71.

20
. De Mendelssohn, A. S. Kasper, and J. Tauscher. 2004. [Neuroimaging in substance abuse disorders]
Nervenarzt
75 (7):651–62. Review.

21
. Littarru, G. P., and P. Langsjoen. 2007. Coenzyme Q10 and statins: Biochemical and clinical implications.
Mitochondrion
7 Suppl:S168–74. Epub March 27, 2007. Review.

22
. Valuck, R. J., and J. M. Ruscin. 2004. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B
₁₂
deficiency in older adults.
J Clin Epidemiol
57 (4):422–28.

23
. Dial, S., et al. 2005. Use of gastric acid-suppressive agents and the risk of community acquired
Clostrium difficile
–associated disease.
JAMA
(23):2989–2995.

24
. Yang, Y. X., et al. 2006. Long-term proton pump inhibitor therapy and risk of hip fracture.
JAMA
296 (24):2947–2953.

25
. Ruscin, J. M., R. L. Page, and R. J. Valuck. 2002. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor.
Ann Pharmacother
36 (5):812–16.

26
. Laine, L., et al. 2000. Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
Aliment Pharmacol Ther
14 (6):651–68. Review.

27
. Atkuri, K. R., J. J. Mantovani, and L. A. Herzenberg. 2007. N—Acetylcysteine—a safe antidote for cysteine/glutathione deficiency.
Curr Opin Pharmacol
7 (4):355–59. Epub June 29, 2007.

28
. Ross, E. A., N. J. Szabo, and I. R. Tebbett. 2000. Lead content of calcium supplements.
JAMA
284 (11):1425–1429.

29
. Thompson, W.W., et al. 2007. Vaccine Safety Datalink Team. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
N Engl J Med
357 (13):1281–1292.

30
. Deppisch, L. M., et al. 1999. Andrew Jackson’s exposure to mercury and lead: Poisoned president?
JAMA
282 (6):569–71.

31
. Guzzi, G., et al. 2006. Dental amalgam and mercury levels in autopsy tissues: Food for thought.
Am J Forensic Med Pathol
27 (1):42–45.

32
. Harris, H. H., et al. 2008. Migration of mercury from dental amalgam through human teeth.
J Synchrotron Radiat
15 (Pt 2):123–28.

33
. Schober, S. E., et al. 2003. Blood mercury levels in US children and women of childbearing age, 1999–2000.
JAMA
289 (13):1667–1674.

34
. www.cfsan.fda.gov/˜acrobat/hgstak56.pdf

35
. Cory-Slechta, D. A. 2005. Studying toxicants as single chemicals: Does this strategy adequately identify neurotoxic risk?
Neurotoxicology
26 (4):491–510. Review.

36
.
www.archive.ewg.org/reports/bodyburden2/execsumm.php

37
. www.vm.cfsan.fda.gov/˜dms/eafus.html.

38
. Alavanja, M. C., J.A. Hoppin, and F. Kamel. 2004. Health effects of chronic pesticide exposure: Cancer and neurotoxicity.
Annu Rev Public Health
25:155–97. Review.

39
. Curl, C. L., R. A. Fenske, and K. Elgethun. 2003. Organophosphorus pesticide exposure of urban and suburban preschool children with organic and conventional diets.
Environ Health Perspect
111 (3):377–82.

40
. Roberts, E. M., et al. 2007. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley.
Environ Health Perspect
115 (10):1482–1489.

41
. Grandjean, P., et al. 2006. Pesticide exposure and stunting as independent predictors of neurobehavioral deficits in Ecuadorian school children.
Pediatrics
117 (3):e546–56.

42
. McCann, D., et al. 2007. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: A randomised, double-blinded, placebo-controlled trial.
Lancet
370 (9598):1560–1567.

43
. Wang, B. L., et al. 2007. Unmetabolized VOCs in urine as biomarkers of low level exposure in indoor environments.
J Occup Health
49 (2):104–10.

44
. Uzun, N., and Y. Kendirli. 2005. Clinical, socio-demographic, neurophysiological and neuropsychiatric evaluation of children with volatile substance addiction.
Child Care Health Dev
31 (4):425–32.

45
. Shoemaker, R. C., and D. E. House. 2006. Sick building syndrome (SBS) and exposure to water-damaged buildings: Time series study, clinical trial and mechanisms.
Neurotoxicol Teratol
28 (5): 573–88. Epub August 7, 2006.

46
. Campbell, A. W., et al. 2003. Neural autoantibodies and neurophysiologic abnormalities in patients exposed to molds in water-damaged buildings.
Arch Environ Health
58 (8):464–74.

47
. Rea, W. J., et al. 2003. Effects of toxic exposure to molds and mycotoxins in building-related illnesses.
Arch Environ Health
58 (7):399–405.

48
. Bellinger, D. C. 2007. Children’s cognitive health: The influence of environmental chemical exposures.
Altern Ther Health Med
13 (2):S140–44. Review.

49
. Needleman, H. L., and C. A. Gatsonis. 1990. Low-level lead exposure and the IQ of children. A metaanalysis of modern studies.
JAMA
263 (5):673–78.

50
. Needleman, H. L., et al. 1990. The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report.
N Engl J Med
322 (2):83–88.

51
. Canfield, R. L., et al. 2003. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter.
N Engl J Med
348 (16):1517– 1526.

52
. Stewart, W. F., and B. S. Schwartz. 2007. Effects of lead on the adult brain: A 15-year exploration.
Am J Ind Med
50 (10):729–39.

53
. Menke, A., et al. 2006. Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults.
Circulation
114 (13):1388–1394.

54
. Romano, C., and M. L. Grossi-Bianchi. 1968. Aphasia and dementia in childhood chronic lead encephalopathy: A curable form of acquired mental impairment.
Panminerva Med
10 (11):448–50.

55
. Choi, B. H. 1989. The effects of methylmercury on the developing brain.
Prog Neurobiol
32 (6):447–70. Review.

56
. Krewski, D., et al. 2007. Recent advances in research on radiofrequency fields and health: 2001–2003.
J Toxicol Environ Health B Crit Rev
10 (4):287–318. Review.

57
. Feychting, M. F., et al. 2003. Occupational magnetic field exposure and neurodegenerative disease.
Epidemiology
14 (4):413–19; Discussion, 427–28.